S
Description
Israeli drug delivery company founded in 2011, specializing in nasal delivery devices for local, systemic and CNS indications. Developed the Cribriform Targeted Device (CT6) for nose-to-brain drug delivery. Technology acquired by Aptar Pharma (~$12.5M). Headquartered in Yokneam, Israel.